Longxiang J. Shen
NO.600 Yishan Road
Shanghai, 200233, China
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Construction of a predictive model for the efficacy of immune checkpoint inhibitors in locally advanced or metastatic gastric cancer and esophagogastric junction cancer
Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: May 20, 2026
DESTINY-Gastric05 phase III trial of first-line trastuzumab deruxtecan, chemotherapy, and pembrolizumab in HER2-positive gastric or gastroesophageal junction cancer.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Clinical research progress and prospects on classification-guided clinical treatment for distal 1/3 of radial fractures
Journal: Zhongguo gu shang = China journal of orthopaedics and traumatology
Published: April 03, 2026
Immunomodulatory carbon dots balance the anti-inflammatory, antibacterial, and osteogenic activities of metal-phenolic network for osteomyelitis therapy.
Journal: Biomaterials
Published: February 23, 2026
Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Dynamically Crosslinked Carbon Dot/Alginate Hydrogels for On-Demand Osteomyelitis Therapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 19, 2026
What is the postoperative prognosis of proximal humeral fractures in China? Protocol for a multicentre prospective cohort study (CAST).
Journal: BMJ open
Published: December 08, 2025
D-π-A sensitized carbon dots as long-lived type-I/Ⅱ photosensitizers for NIR-excited hypoxia-regulated photodynamic therapy.
Journal: Nature communications
Published: October 28, 2025
A randomised study of encorafenib, cetuximab, and FOLFIRI versus FOLFIRI with or without bevacizumab in BRAF V600E-mutant colorectal cancer: BREAKWATER Cohort 3.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 01, 2025
Atomic-valence engineering of a Mn(III)-tuned sonozyme system for multimodal tumor immunotherapy.
Journal: Biomaterials
Published: September 29, 2025
Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 24, 2025
Final overall survival analysis and exploratory biomarker study from JUPITER-06: a randomized phase III trial of toripalimab plus chemotherapy in advanced esophageal squamous-cell carcinoma.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 24, 2025
Last Updated: 09/26/2026